✦ LIBER ✦

Infections in Renal Transplant Recipients Receiving Mycophenolate Versus Azathioprine-Based Immunosuppression

✍ Scribed by M. Bernabeu-Wittel; M. Naranjo; J. Cisneros; E. Cañas; M. Gentil; G. Algarra; P. Pereira; F. González-Roncero; A. de Alarcón; J. Pachón

Publisher: Springer
Year: 2002
Tongue: English
Weight: 87 KB
Volume: 21
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-001-0684-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

“Triple infections” (fungal, bacterial a

“Triple infections” (fungal, bacterial and viral) in immunosuppressed renal transplant recipients

✍ J. Zazgornik; P. Schmidt; H. Kopsa; Josephine Thurner; E. Deutsch 📂 Article 📅 1979 🏛 Springer Netherlands 🌐 English ⚖ 362 KB

Predictors and outcome of early- versus

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression

✍ N. Singh; T. Gayowski; M. M. Wagener; I. R. Marino 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 613 KB

Economic evaluation of everolimus versus

Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients

✍ Michael Holmes; Jim Chilcott; Stephen Walters; Simon Whitby; Ron Akehurst 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 170 KB

Molecular-based strategies for assessmen

Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients

✍ A. Kulkarni; D. Westmoreland; J. D. Fox 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

A prospective cross-over study comparing

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

✍ Amany Zekry; Margret Gleeson; Seren Guney; Geoffrey W. McCaughan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

It has been suggested that Mycophenolate Mofetil (MMF) may have an antiviral effect in patients with recurrent HCV infection post-liver transplantation. We conducted a prospective cross-over study in liver transplant recipients with recurrent chronic HCV infection to examine whether substitution of

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos